These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21710160)

  • 21. Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study.
    Hanberger H; Walther S; Leone M; Barie PS; Rello J; Lipman J; Marshall JC; Anzueto A; Sakr Y; Pickkers P; Felleiter P; Engoren M; Vincent JL;
    Int J Antimicrob Agents; 2011 Oct; 38(4):331-5. PubMed ID: 21798720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Teicoplanin therapy for MRSA bacteraemia: a retrospective study emphasizing the importance of maintenance dosing in improving clinical outcomes.
    Lee CH; Tsai CY; Li CC; Chien CC; Liu JW
    J Antimicrob Chemother; 2015 Jan; 70(1):257-63. PubMed ID: 25190719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
    Gawronski KM; Goff DA; Brown J; Khadem TM; Bauer KA
    Clin Ther; 2013 Jun; 35(6):772-9. PubMed ID: 23795575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced loading regimen of teicoplanin is necessary to achieve therapeutic pharmacokinetics levels for the improvement of clinical outcomes in patients with renal dysfunction.
    Ueda T; Takesue Y; Nakajima K; Ichiki K; Doita A; Wada Y; Tsuchida T; Takahashi Y; Ishihara M; Ikeuchi H; Uchino M; Kimura T
    Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1501-9. PubMed ID: 27278654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Borate Bioactive Glass and Calcium Sulfate as Implants for the Local Delivery of Teicoplanin in the Treatment of Methicillin-Resistant Staphylococcus aureus-Induced Osteomyelitis in a Rabbit Model.
    Jia WT; Fu Q; Huang WH; Zhang CQ; Rahaman MN
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7571-80. PubMed ID: 26416858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methicillin-resistant Staphylococcus aureus in North-east Croatia.
    Pastuović T; Perić M; Bošnjak Z; Ružman N; Majić PR; Talapko J; Atalić V; Loci-Zvocak S; Vuković D
    Acta Med Acad; 2015; 44(1):10-7. PubMed ID: 26062693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of teicoplanin and linezolid therapies in patients with methicillin-resistant Staphylococcus aureus pneumonia acquired from respiratory intensive care unit].
    Taşbakan MS; Korkmaz Ekren P; Pullukçu H; Başarık B; Susur A; Aydemir S; Başoğlu OK; Bacakoğlu F
    Mikrobiyol Bul; 2010 Jul; 44(3):357-66. PubMed ID: 21063985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a teicoplanin loading regimen that rapidly achieves target serum concentrations in critically ill patients with severe infections.
    Nakamura A; Takasu O; Sakai Y; Sakamoto T; Yamashita N; Mori S; Morita T; Nabeta M; Hirayu N; Yoshiyama N; Moroki M; Tashiro K; Kannae M
    J Infect Chemother; 2015 Jun; 21(6):449-55. PubMed ID: 25726436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia.
    Jung Y; Song KH; Cho Je; Kim HS; Kim NH; Kim TS; Choe PG; Chung JY; Park WB; Bang JH; Kim ES; Park KU; Park SW; Kim HB; Kim NJ; Oh MD
    Int J Antimicrob Agents; 2014 Feb; 43(2):179-83. PubMed ID: 24315788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hospital Pharmacometrics for Optimal Individual Administration of Antimicrobial Agents for Anti-methicillin-resistant Staphylococcus aureus Infected Patients.
    Tsuji Y
    Biol Pharm Bull; 2021; 44(9):1174-1183. PubMed ID: 34471044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia with high-dose vancomycin or linezolid.
    Hamilton LA; Christopher Wood G; Magnotti LJ; Croce MA; Martin JB; Swanson JM; Boucher BA; Fabian TC
    J Trauma Acute Care Surg; 2012 Jun; 72(6):1478-83. PubMed ID: 22695410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treating Staphylococcus aureus infections in an intensive care unit at a University Hospital in Brazil.
    Gimenes M; Salci TP; Tognim MC; Siqueira VL; Caparroz-Assef SM
    Int J Clin Pharm; 2016 Apr; 38(2):228-32. PubMed ID: 26971114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycopeptide pharmacokinetics in current paediatric cardiac surgery practice.
    Shime N; Kato Y; Kosaka T; Kokufu T; Yamagishi M; Fujita N
    Eur J Cardiothorac Surg; 2007 Oct; 32(4):577-81. PubMed ID: 17689968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nephrotoxicity of vancomycin in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Shen WC; Chiang YC; Chen HY; Chen TH; Yu FL; Tang CH; Sue YM
    Nephrology (Carlton); 2011 Nov; 16(8):697-703. PubMed ID: 21707841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of clinical and microbiological treatment failure in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence.
    Forstner C; Dungl C; Tobudic S; Mitteregger D; Lagler H; Burgmann H
    Clin Microbiol Infect; 2013 Jul; 19(7):E291-7. PubMed ID: 23490021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and pharmacodynamics of teicoplanin given daily during the first 3 days and then on alternate days for methicillin-resistant Staphylococcus aureus infections.
    Bantar C; Durlach R; Nicola F; Freuler C; Bonvehí P; Vazquez R; Smayevsky J
    J Antimicrob Chemother; 1999 May; 43(5):737-40. PubMed ID: 10382901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of High Trough Concentration of Teicoplanin in the Treatment of Methicillin-Resistant Staphylococcus aureus Infection.
    Sato Y; Tokimatsu I; Suzuki Y; Itoh H; Hiramatsu K; Kadota J
    Chemotherapy; 2014; 60(4):274-8. PubMed ID: 25926288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
    Shoji H; Maeda M; Shirakura T; Takuma T; Ugajin K; Fukuchi K; Ishino K; Niki Y
    Int J Antimicrob Agents; 2015 Nov; 46(5):532-7. PubMed ID: 26364848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy.
    Joo J; Yamaki J; Lou M; Hshieh S; Chu T; Shriner KA; Wong-Beringer A
    Clin Ther; 2013 Jul; 35(7):995-1004. PubMed ID: 23829982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use.
    Garrouste-Orgeas M; Timsit JF; Kallel H; Ben Ali A; Dumay MF; Paoli B; Misset B; Carlet J
    Infect Control Hosp Epidemiol; 2001 Nov; 22(11):687-92. PubMed ID: 11842988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.